Imexpharm Corp
VN:IMP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Imexpharm Corp
VN:IMP
|
VN |
|
Red Violet Inc
NASDAQ:RDVT
|
US |
|
SigmaTron International Inc
NASDAQ:SGMA
|
US |
|
Y
|
Yi Hua Holdings Ltd
HKEX:2213
|
CN |
|
X
|
XPON Technologies Group Ltd
ASX:XPN
|
AU |
|
T
|
Tong Hua Holding PCL
SET:TH
|
TH |
|
A
|
Alpha Pro Tech Ltd
F:APL
|
CA |
Wall Street
Price Targets
IMP Price Targets Summary
Imexpharm Corp
According to Wall Street analysts, the average 1-year price target for IMP is 56 440 VND with a low forecast of 54 035 VND and a high forecast of 59 325 VND.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IMP's stock price target?
Price Target
56 440
VND
According to Wall Street analysts, the average 1-year price target for IMP is 56 440 VND with a low forecast of 54 035 VND and a high forecast of 59 325 VND.
What is Imexpharm Corp's Revenue forecast?
Projected CAGR
18%
For the last 14 years the compound annual growth rate for Imexpharm Corp's revenue is 9%. The projected CAGR for the next 3 years is 18%.
What is Imexpharm Corp's Operating Income forecast?
Projected CAGR
21%
For the last 14 years the compound annual growth rate for Imexpharm Corp's operating income is 11%. The projected CAGR for the next 3 years is 21%.
What is Imexpharm Corp's Net Income forecast?
Projected CAGR
16%
For the last 14 years the compound annual growth rate for Imexpharm Corp's net income is 10%. The projected CAGR for the next 3 years is 16%.
